# REVIparin-BRIDging-in a General Practice Setting in GErmany

> **NCT02579122** · — · TERMINATED · sponsor: **Mylan Inc.** · enrollment: 77 (actual)

## Conditions studied

- Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02579122
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 77 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579122, "REVIparin-BRIDging-in a General Practice Setting in GErmany". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02579122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*